Literature DB >> 9447906

Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991-1995.

G Weber1, K Riesenberg, F Schlaeffer, N Peled, A Borer, P Yagupsky.   

Abstract

In order to monitor changes in the frequency and antimicrobial resistance of urinary pathogens over several years, urinary cultures received from outpatient clinics and from a hospital during a period of one month each in 1991 and 1995 were analyzed at a clinical microbiology laboratory. In 1991 and 1995, 1366 and 1534 significant monomicrobic cultures respectively were reviewed. The frequency of Escherichia coli dropped significantly in the outpatient clinics from 70.5% to 61.2% (p < 0.0001). The frequency of Proteus mirabilis, Morganella morganii, Pseudomonas aeruginosa and other gram-negative bacteria also decreased, but the frequency of Klebsiella spp. and Enterobacter spp. increased from 2.6% to 5.8% (p < 0.0001). In the hospital, the frequency of Enterobacter spp. (p < 0.04), Escherichia coli and Morganella morganii declined from 1991 to 1995, whereas the frequency of Pseudomonas aeruginosa (p = 0.001), Acinetobacter spp. (p < 0.05), Klebsiella spp., Proteus mirabilis and other gram-negative rods increased considerably. The frequency of gram-positive aerobic bacteria rose markedly in outpatient specimens from 6.1% to 13.5% (p < 0.0001), while a decline from 14.4% to 9.3% was noted in hospital specimens (p < 0.02). A significant rise in the resistance of Escherichia coli to gentamicin and ciprofloxacin (p < 0.0001) was detected in outpatient isolates. In the hospital, gram-negative urinary pathogens demonstrated increased resistance to ampicillin (p = 0.042), cefuroxime (p = 0.005), gentamicin (p = 0.002) and ciprofloxacin (p < 0.0001) during the study period. The changing etiology of urinary tract infections and the increasing resistance of organisms indicate that periodic monitoring and possibly also modification of empirical therapy are required.

Entities:  

Mesh:

Year:  1997        PMID: 9447906     DOI: 10.1007/bf01700414

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

1.  Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center.

Authors:  R R Muder; C Brennen; A M Goetz; M M Wagener; J D Rihs
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 2.  Interaction between antimicrobial consumption and selection of resistant bacterial strains.

Authors:  R C Moellering
Journal:  Scand J Infect Dis Suppl       Date:  1990

3.  Development of erythromycin-resistance in Staphylococcus aureus as a consequence of high erythromycin consumption.

Authors:  H Westh; B L Jensen; V T Rosdahl; J Prag
Journal:  J Hosp Infect       Date:  1989-08       Impact factor: 3.926

Review 4.  Urinary tract infections.

Authors:  H C Neu
Journal:  Am J Med       Date:  1992-04-06       Impact factor: 4.965

5.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

Review 6.  Antibiotic resistance in developing countries.

Authors:  W E Farrar
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

7.  Secular trends in rates and etiology of nosocomial urinary tract infections at a university hospital.

Authors:  D A Bronsema; J R Adams; R Pallares; R P Wenzel
Journal:  J Urol       Date:  1993-08       Impact factor: 7.450

8.  Urinary tract infections in females.

Authors:  C M Kunin
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

9.  Enterococcus species in urinary tract infection.

Authors:  D Felmingham; A P Wilson; A I Quintana; R N Grüneberg
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079

10.  Nosocomial urinary tract infections: secular trends, treatment and economics in a university hospital.

Authors:  J N Krieger; D L Kaiser; R P Wenzel
Journal:  J Urol       Date:  1983-07       Impact factor: 7.450

View more
  8 in total

1.  Risk factors for non-Escherichia coli community-acquired bacteriuria.

Authors:  M A Amna; B Chazan; R Raz; H Edelstein; R Colodner
Journal:  Infection       Date:  2012-10-11       Impact factor: 3.553

2.  Risk factors for bacteriuria due to Pseudomonas aeruginosa or Enterococcus spp in patients hospitalized via the emergency department.

Authors:  D Raveh; I Rosenzweig; B Rudensky; Y Wiener-Well; A M Yinnon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-05       Impact factor: 3.267

3.  Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection.

Authors:  D Prais; R Straussberg; Y Avitzur; M Nussinovitch; L Harel; J Amir
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

4.  Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006.

Authors:  Ferhat Catal; Nuket Bavbek; Omer Bayrak; Musemma Karabel; Duran Karabel; Ender Odemis; Ebru Uz
Journal:  Int Urol Nephrol       Date:  2008-08-14       Impact factor: 2.370

5.  Rapid qualitative urinary tract infection pathogen identification by SeptiFast real-time PCR.

Authors:  Lutz E Lehmann; Stefan Hauser; Thomas Malinka; Sven Klaschik; Stefan U Weber; Jens-Christian Schewe; Frank Stüber; Malte Book
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

6.  Isolation and Molecular Detection of Gram Negative Bacteria Causing Urinary Tract Infection in Patients Referred to Shahrekord Hospitals, Iran.

Authors:  Elahe Tajbakhsh; Sara Tajbakhsh; Faham Khamesipour
Journal:  Iran Red Crescent Med J       Date:  2015-05-31       Impact factor: 0.611

7.  Urinary tract infection among intellectual disability individuals "etiology and antibiotic resistance patterns" in rehabilitation centers of Mazandaran province, Northern Iran.

Authors:  M Nasrolahei; M Poorhagibagher; M Vahedi; I Maleki
Journal:  J Prev Med Hyg       Date:  2013-09

8.  Evaluation of the Live Biotherapeutic Product, Asymptomatic Bacteriuria Escherichia coli 2-12, in Healthy Dogs and Dogs with Clinical Recurrent UTI.

Authors:  G Segev; J E Sykes; D J Klumpp; A J Schaeffer; E M Antaki; B A Byrne; R E Yaggie; J L Westropp
Journal:  J Vet Intern Med       Date:  2017-12-15       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.